Fundraising Fox

Epicore Biosystems

Cambridge, US · Founded 2017 · Delaware corporation · 2 known investors

Biotechin /epicore-biosystems

Founders & leadership

RG
Roozbeh GhaffariExecutive Officer, Director
JR
John RogersDirector
AJ
Alexander J. AranyosiExecutive Officer
SL
Stephen LeeExecutive Officer
JR
James RyanExecutive Officer
JW
John WrightExecutive Officer
JM
Jeffrey ModelExecutive Officer
WL
Weihua LiExecutive Officer
KQ
Kimberly QuerreyDirector
LL
Laura LangDirector

Investors · 2

Castor Ventures (an Alumni Ventures Fund)
Joyance PartnersBerlin

Reported raises · per SEC filings

Form D private placements
▶$25.7MraisedApr 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen LeeExecutive Officer
  • James RyanExecutive Officer
  • Kimberly QuerreyDirector
  • John WrightExecutive Officer
  • Jeffrey ModelExecutive Officer
  • Roozbeh GhaffariExecutive Officer, Director
  • John RogersDirector
  • Alexander J. AranyosiExecutive Officer
  • Weihua LiExecutive Officer
  • Laura LangDirector
Offering amount
$35M
Amount sold
$25.7M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedFeb 2024 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES RYANExecutive Officer
  • JEFF MODELExecutive Officer
  • JOHN ROGERSDirector
  • STEPHEN LEEExecutive Officer
  • JOHN WRIGHTExecutive Officer
  • ROOZBEH GHAFFARIExecutive Officer, Director
  • LAURA LANGDirector
Offering amount
$10M
Amount sold
$1.5M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.5MraisedFeb 2022 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ROOZBEH GHAFFARIExecutive Officer, Director
  • JOHN ROGERSDirector
Offering amount
$10M
Amount sold
$9.5M
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$350KraisedOct 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John RogersExecutive Officer, Director
  • Roozbeh GhaffariExecutive Officer, Director
Offering amount
$1M
Amount sold
$350K
First sale
Oct 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.